Medina E, Pieper DH. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria. Curr Top Microbiol Immunol 2016;398:3–33. DOI: 10.1007/82_2016_492.
Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. The Lancet 2024;404:1199–226. DOI: 10.1016/S0140-6736(24)01867-1.
Bhattacharya S. Is screening patients for antibiotic-resistant bacteria justified in the Indian context? Indian J Med Microbiol 2011;29:213–7. DOI: 10.4103/0255-0857.83902.
Rice LB. Controlling antibiotic resistance in the ICU: different bacteria, different strategies. Cleve Clin J Med 2003;70:793–800. DOI: 10.3949/ccjm.70.9.793.
Blot S, Ruppé E, Harbarth S, Asehnoune K, Poulakou G, Luyt C-E, et al. Healthcare-associated infections in adult intensive care unit patients: Changes in epidemiology, diagnosis, prevention and contributions of new technologies. Intensive Crit Care Nurs 2022;70:103227. DOI: 10.1016/j.iccn.2022.103227.
Bar Ilan M, Kjerulf A. Who should be screened for carbapenemase-producing Enterobacterales and when? A systematic review. J Hosp Infect 2023;142:74–87. DOI: 10.1016/j.jhin.2023.09.018.
Abramowicz L, Gerard M, Martiny D, Delforge M, De Wit S, Konopnicki D. Infections due to carbapenemase-producing bacteria, clinical burden, and impact of screening strategies on outcome. Médecine Mal Infect 2020;50:658–64. DOI: 10.1016/j.medmal.2019.12.011.
Räisänen K, Lyytikäinen O, Kauranen J, Tarkka E, Forsblom-Helander B, Grönroos JO, et al. Molecular epidemiology of carbapenemase-producing Enterobacterales in Finland, 2012–2018. Eur J Clin Microbiol Infect Dis 2020;39:1651–6. DOI: 10.1007/s10096-020-03885-w.
Otter JA, Mookerjee S, Davies F, Bolt F, Dyakova E, Shersing Y, et al. Detecting carbapenemase-producing Enterobacterales (CPE): an evaluation of an enhanced CPE infection control and screening programme in acute care. J Antimicrob Chemother 2020;75:2670–6. DOI: 10.1093/jac/dkaa192.
Vincent J-L, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, et al. Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017. JAMA 2020;323:1478–87. DOI: 10.1001/jama.2020.2717.
Campion M, Scully G. Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation. J Intensive Care Med 2018;33:647–55. DOI: 10.1177/0885066618762747.
Londero A, Costa M, Sucari A, Leotta G. Comparison of three molecular subtyping techniques for Listeria monocytogenes. Rev Argent Microbiol Argent J Microbiol 2019;51:359–62. DOI: 10.1016/j.ram.2019.01.003.
Coșeriu RL, Vintilă C, Mare AD, Ciurea CN, Togănel RO, Cighir A, et al. Epidemiology, Evolution of Antimicrobial Profile and Genomic Fingerprints of Pseudomonas aeruginosa before and during COVID-19: Transition from Resistance to Susceptibility. Life 2022;12:2049. DOI: 10.3390/life12122049.